University Of Washington
Clinical trials sponsored by University Of Washington, explained in plain language.
-
New vaccine aims to train immune system against breast cancer stem cells
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests a DNA vaccine called STEMVAC in 42 people with advanced HER2-negative breast cancer whose disease is stable or gone after standard treatment. The vaccine is designed to help the immune system recognize and attack cancer stem cells, which are often res…
Phase: PHASE1 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 22, 2026 12:03 UTC
-
Could a tiny HPV shot still protect? new study tests smaller doses
⭐️ VACCINE ⭐️ OngoingThis study looks at whether a smaller, skin-deep dose of the HPV vaccine can trigger a strong immune response in adults aged 27 to 45. About 40 participants will receive either a bivalent or nonavalent HPV vaccine as a single fractional injection. Researchers will measure antibod…
Phase: PHASE4 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 16, 2026 12:51 UTC
-
Could a smaller HPV vaccine dose still protect adults?
⭐️ VACCINE ⭐️ OngoingThis study looks at whether giving a smaller (one-fifth) dose of the HPV vaccine, either into the skin or muscle, can still trigger a strong immune response in adults aged 27 to 45. About 92 men and women in Seattle will have their antibody levels checked over a year. The goal is…
Phase: PHASE4 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 16, 2026 12:48 UTC
-
New vaccine aims to train immune system to fight triple negative breast cancer
⭐️ VACCINE ⭐️ OngoingThis study tests a DNA-based vaccine called STEMVAC in 33 people with early-stage triple negative breast cancer. The vaccine targets proteins found on breast cancer stem cells and aims to train the immune system to recognize and destroy these cells. The main goal is to see if the…
Phase: PHASE2 • Sponsor: University of Washington • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 09, 2026 12:08 UTC
-
Quick urine test could help south africans stay on HIV meds
Disease control OngoingThis study tests whether giving people with HIV their viral load and medication-level results on the same day helps them stay on treatment and keep the virus under control. About 539 adults starting HIV therapy in South Africa will get these quick tests. The goal is to see if thi…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 23, 2026 19:32 UTC
-
DNA vaccine aims to train immune system against lung cancer
Disease control OngoingThis phase II trial tests a DNA vaccine called STEMVAC in 5 people with stage IV non-small cell lung cancer. The vaccine gives the body instructions to make parts of five proteins found on lung cancer cells, with the goal of activating immune cells to attack the tumor. Participan…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 23, 2026 12:01 UTC
-
Could a common muscle drug and vitamin e heal jaw bone death?
Disease control OngoingThis phase 3 trial tests whether a combination of pentoxifylline (a muscle pain drug) and vitamin E can help heal jaw bone damage caused by osteoporosis or cancer treatments. About 100 people with medication-related jaw bone death will receive either the drug combo plus standard …
Phase: PHASE3 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New combo aims to halt ovarian cancer recurrence
Disease control OngoingThis phase II trial tests whether combining the immunotherapy drug pembrolizumab (Keytruda) with the chemotherapy carboplatin can prevent or delay cancer progression in women with recurrent ovarian, fallopian tube, or primary peritoneal cancer. The study enrolls 22 participants w…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New hope for rare bleeding disorder: emicizumab trial launches
Disease control OngoingThis phase 2 trial tests the drug emicizumab (Hemlibra) as a regular injection to prevent bleeding in 51 adults with acquired hemophilia A, a rare condition where the immune system attacks clotting factors. Participants receive two loading doses then weekly shots, along with stan…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
Text messages empower HIV-positive women to take control of family planning
Disease control OngoingThis study tests whether text messages and counseling can help women living with HIV make better decisions about contraception and pregnancy. About 3,310 women in Kenya will receive either standard care or the mobile health program. The goal is to reduce unplanned pregnancies and…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
ER-Based care program aims to curb opioid use and keep patients in treatment
Disease control OngoingThis study tests a program called ED LINC, which provides coordinated care starting in the emergency department for people with opioid use disorder. About 500 adults with moderate to severe opioid use disorder will either receive this program or usual care. The goal is to see if …
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 17, 2026 12:10 UTC
-
New weekly combo offers hope for hard-to-treat lymphoma
Disease control OngoingThis study tests whether giving the drug brentuximab vedotin weekly, alone or with nivolumab, can shrink tumors in people with CD30+ lymphoma that no longer responds to the usual every-3-week dosing. About 28 adults with relapsed or refractory Hodgkin or non-Hodgkin lymphoma will…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New 4-Drug cocktail shows promise for Tough-to-Treat myeloma
Disease control OngoingThis study tests a combination of four drugs (isatuximab, carfilzomib, pomalidomide, and dexamethasone) in 30 adults whose multiple myeloma has returned or is not responding to prior treatments. The goal is to see how well this drug mix shrinks or controls the cancer. Participant…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New drug combo targets BRCA cancers in early trial
Disease control OngoingThis early-phase study tests a combination of two drugs, niraparib and dostarlimab, in 18 adults with BRCA-mutated breast, pancreas, or ovary cancer that has spread or cannot be surgically removed. Niraparib blocks a DNA repair protein in cancer cells, while dostarlimab helps the…
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New drug combo shows promise for Hard-to-Treat prostate cancer
Disease control OngoingThis study tests whether combining two drugs, golimumab and apalutamide, can help men with a type of advanced prostate cancer that no longer responds to standard hormone therapy. The goal is to see if this combination can lower PSA levels by at least 50%. Eight participants are e…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
New hope for rare gut tumors: drug slows cancer growth in trial
Disease control OngoingThis study tests a drug called abemaciclib in 20 people with advanced digestive neuroendocrine tumors that have stopped responding to standard treatments and cannot be surgically removed. The drug works by blocking certain enzymes that help cancer cells grow. The goal is to see i…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New program aims to keep hospital patients on track for opioid and meth recovery
Disease control OngoingThis study tests a program called MIAPP that adds a patient navigator, smartphone check-ins, and small rewards to usual care for people who start buprenorphine for opioid use in the hospital and also use methamphetamine. The goal is to help them connect to outpatient treatment wi…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Home BP checks may prevent dangerous drops during dialysis
Disease control OngoingThis study tests whether measuring blood pressure at home, rather than only at the dialysis center, helps prevent dangerous blood pressure drops during dialysis. 200 adults with end-stage kidney disease on dialysis will be assigned to either home or clinic blood pressure targets.…
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
New drug combo shows promise for slowing lymphoma growth
Disease control OngoingThis study tests a combination of two drugs, ixazomib and rituximab, in people with slow-growing B-cell non-Hodgkin lymphoma. The goal is to see how well the drugs shrink or control the cancer. About 33 adults with different types of this lymphoma are taking part.
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
New combo therapy shows promise for Hard-to-Treat lymphoma
Disease control OngoingThis study tests whether adding the drug acalabrutinib to CAR T-cell therapy (a treatment that uses a patient's own immune cells to fight cancer) is safe and effective for adults with certain types of B-cell lymphoma. About 23 participants will receive the combination. The goal i…
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New combo therapy shows promise for Tough-to-Treat blood cancer
Disease control OngoingThis study tests whether adding a targeted drug called tafasitamab to standard chemotherapy can improve treatment for adults newly diagnosed with a fast-growing blood cancer (Ph- B-ALL). About 32 adults who cannot receive standard intensive chemo will get the combination. The goa…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
Triple immunotherapy attack shows promise for tough skin cancer
Disease control OngoingThis study tests a combination of three immunotherapy drugs (INCMGA00012, INCAGN02385, and INCAGN02390) in 12 adults with advanced Merkel cell carcinoma that continued to grow after standard treatment. The drugs are given by IV to help the immune system fight the cancer. The main…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
Immunotherapy drug aims to stop deadly skin cancer's return in high-risk patients
Disease control OngoingThis phase 3 trial tests whether the immunotherapy drug avelumab can keep Merkel cell carcinoma from returning in patients whose cancer has spread to lymph nodes and who have already had surgery or radiation. About 100 adults will receive either avelumab or a placebo every two we…
Phase: PHASE3 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC
-
New ultrasound software aims to sharpen kidney stone detection
Diagnosis OngoingThis study tests whether new software for ultrasound machines can improve how doctors find and measure kidney stones. Researchers will compare the new ultrasound images to standard clinical methods in 370 adults with calcium-based kidney stones. The goal is to make diagnosis more…
Phase: NA • Sponsor: University of Washington • Aim: Diagnosis
Last updated Jun 22, 2026 11:56 UTC
-
5-Minute MRI scan could spot hidden breast cancers without needles or dye
Diagnosis OngoingThis study is testing a short (under 5 minutes) MRI technique called DWI that does not require an injection of contrast dye. The goal is to see if it can find breast cancers that mammograms miss in women with dense breasts. About 269 women with dense breasts will participate. If …
Sponsor: University of Washington • Aim: Diagnosis
Last updated Jun 16, 2026 12:50 UTC
-
New scan could sharpen prostate cancer detection
Diagnosis OngoingThis study tests a special PET scan (68Ga-PSMA-11) to see if it can find and monitor prostate cancer more accurately than standard scans. About 141 men with prostate cancer that has come back or spread will get the scan. The goal is to help doctors choose the best treatment.
Phase: PHASE2 • Sponsor: University of Washington • Aim: Diagnosis
Last updated Jun 15, 2026 19:09 UTC
-
Can storytelling keep native teens away from drugs and alcohol?
Prevention OngoingThis study tests a program called Journey of Transformation for Native American tenth graders at an off-reservation boarding school. The program uses traditional storytelling, cultural arts, and outdoor activities to teach leadership and healthy decision-making around substance u…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 23, 2026 11:55 UTC
-
Kenya tests new way to get HIV prevention pills to 17,000 pregnant women
Prevention ENROLLING_BY_INVITATIONThis study aims to help Kenyan clinics offer PrEP (HIV prevention pills) to pregnant and postpartum women more effectively. Researchers will provide clinics with a training toolkit, quality improvement support, and a community of practice for staff. The goal is to see if this pac…
Phase: PHASE4 • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 22, 2026 12:01 UTC
-
Pharmacy navigators boost HIV prevention in kenyan teens
Prevention OngoingThis study tests whether nurse-navigators can help adolescent girls and young women in Kenya start and continue taking PrEP, a daily medication that prevents HIV. About 1,900 participants will get PrEP at local pharmacies after buying birth control, and half will also receive ext…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 15, 2026 19:04 UTC
-
Phone-Based group therapy aims to stop postpartum depression before it starts
Prevention OngoingThis study tests a 12-week digital group program called IMAGINE to see if it can prevent depression in pregnant people and new mothers who are at higher risk. About 100 participants will either join the online group or receive standard care. Researchers will check depression and …
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 12, 2026 12:05 UTC
-
Sound waves could push kidney stones out without surgery
Symptom relief OngoingThis study tests a device that uses focused ultrasound to gently push kidney stones, helping them pass or relieving pain. Researchers are enrolling 172 people with kidney stones, including those waiting for treatment or recently treated. The goal is to see if the ultrasound can m…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 23, 2026 19:18 UTC
-
Can zoom yoga beat cancer fatigue? small study tests digital fix
Symptom relief OngoingThis pilot study tests whether a virtual mind-body program called IM@Home can help breast cancer patients manage fatigue and other symptoms during radiation therapy. The program includes online cardio and yoga classes, plus a FitBit to track activity. Researchers will enroll 40 p…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 23, 2026 11:59 UTC
-
Hypnosis therapy shows promise for spinal cord injury pain relief
Symptom relief OngoingThis study tests a treatment called Hypnosis Enhanced Cognitive Therapy (HYPCT) for people with new spinal cord injuries who are in rehab. It compares HYPCT to standard pain education to see if it can lower pain intensity and prevent chronic pain. Participants will attend four se…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 23, 2026 11:55 UTC
-
New app aims to make toothbrushing easier for children with autism
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a special app can help children and teens (ages 8-17) with autism improve their toothbrushing. Participants use either the autism-friendly app or a basic control app for 3 months. Researchers will check if the app leads to better brushing coverage, longer…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 22, 2026 12:08 UTC
-
Nurse program aims to ease chronic pain in rural america
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a nurse care management program can help rural adults with chronic pain feel better and function more in daily life. The program includes care coordination, cognitive behavioral therapy, and referrals to an exercise program. About 450 rural patients will …
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 22, 2026 12:05 UTC
-
New study aims to bring autism therapy to more kids through public system
Symptom relief OngoingThis study tests whether training early intervention providers in Reciprocal Imitation Training can help children with autism improve imitation and communication skills. The program involves 440 children and their caregivers, with providers learning simple strategies during play.…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 22, 2026 11:57 UTC
-
Could ecstasy help treat narcissism? small study explores MDMA therapy
Symptom relief OngoingThis early-phase study tests whether MDMA-assisted therapy can help people with pathological narcissism. Twelve adults will receive three monthly MDMA sessions plus therapy, with follow-up over six months. The goal is to see if symptoms improve and if the treatment is safe.
Phase: EARLY_PHASE1 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 18, 2026 11:53 UTC
-
Surgery or pills? new study tackles diverticulitis dilemma
Symptom relief OngoingThis study compares surgery (removing part of the colon) to the best medical treatments for people whose diverticulitis symptoms seriously affect their daily life. About 255 adults with at least one confirmed episode of diverticulitis and ongoing quality-of-life issues are taking…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 18, 2026 11:51 UTC
-
New program aims to ease loneliness in cancer survivors
Symptom relief ENROLLING_BY_INVITATIONThis study tests a program designed to reduce loneliness and improve well-being in cancer survivors. Researchers will work with 36 adults who have had cancer and feel lonely. The program uses social prescribing to help participants build connections and improve their quality of l…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 18, 2026 11:46 UTC
-
New program aims to cut PTSD and ER visits for trauma patients
Symptom relief OngoingThis study tests a brief stepped care program for adults hospitalized after a traumatic injury who show signs of PTSD. The program starts in the hospital and aims to reduce PTSD symptoms and the number of emergency room visits over time. About 424 participants are involved, and t…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
Text messages may help young adults cut back on cannabis
Symptom relief OngoingThis study tests a new mobile health program for young adults ages 18-29 who use cannabis frequently or use high-potency products. Participants receive personalized feedback and weekly text messages to reflect on their cannabis use and personal goals. The program aims to reduce t…
Phase: NA • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 15, 2026 19:03 UTC
-
Can a phone call and online tools save lives? new study aims to boost cancer screening in High-Risk patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests two simple, scalable methods to help people with inherited cancer risk follow through on recommended screenings. Researchers will provide online educational resources and personalized phone outreach to 900 participants. The goal is to see if these approaches impr…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:59 UTC
-
One-Size-Fits-All pain treatment fails many – new study aims to match you to the right therapy
Knowledge-focused OngoingThis study looks at whether matching people with chronic pain to a specific type of talk therapy—like cognitive behavioral therapy, mindfulness, or hypnosis—can lead to better pain relief. About 331 adults with chronic pain will be randomly assigned to one of these treatments. Th…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:08 UTC
-
Bladder cancer study aims to end treatment guesswork
Knowledge-focused OngoingThis study compares two treatments for a type of bladder cancer that keeps coming back: medication placed directly into the bladder or surgery to remove the bladder. Researchers want to see which option gives patients a better quality of life and fewer side effects. About 570 adu…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC
-
Shingrix vaccine study reveals how immune cells protect skin in older adults
Knowledge-focused OngoingThis study looks at how the Shingrix vaccine, which prevents shingles, changes immune cells in the skin and blood. Researchers will compare two groups: adults aged 30-40 and those 70 or older. The goal is to understand how the vaccine creates long-lasting protection, especially i…
Phase: PHASE4 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC
-
Morning or evening? study seeks best time for brain training after ICU
Knowledge-focused OngoingThis study looks at whether doing computer-based brain exercises in the morning or late afternoon works better for older adults who have been in the intensive care unit (ICU). Many ICU survivors have trouble thinking clearly and sleeping well. The goal is to see which time of day…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:46 UTC
-
Texts of kindness: could a simple message save a Veteran's life?
Knowledge-focused OngoingThis study looks at whether sending caring text messages to stressed or distressed veterans and service members can lower their emotional pain and reduce thoughts of suicide. Over 500 participants will receive either the caring messages plus helpful resources, or just the resourc…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 17, 2026 12:06 UTC
-
New study aims to help cystic fibrosis patients discuss lung transplants earlier
Knowledge-focused OngoingThis study tests whether a research website helps people with cystic fibrosis (CF) feel more prepared to discuss lung transplant with their doctors. About 132 adults with CF and low lung function will use the website and attend Zoom sessions over 6 months. The goal is to increase…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC
-
Can a smart online tool help cities beat the heat?
Knowledge-focused OngoingThis study tests a new online decision-support tool that helps local health departments identify heat risks in their communities and choose effective ways to respond. Researchers will compare health departments that use the tool with those that only receive general heat-health in…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
Lab tests could pick the right drug for tough myeloma cases
Knowledge-focused OngoingThis study tests a new way to choose treatments for people with multiple myeloma or plasma cell leukemia that has returned or stopped responding to standard therapy. Researchers use a lab test that checks many drugs at once, along with genetic information, to find which drug or d…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
Writing your future self: a 20-Minute exercise may curb risky drinking after high school
Knowledge-focused OngoingThis study looks at whether a 20-minute writing task, called the Future Possible Self Task (FPST), can help high school seniors and recent graduates think differently about drinking and reduce alcohol misuse. About 468 participants will complete the writing exercise and answer qu…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC
-
New imaging technique tracks breast cancer treatment response in real time
Knowledge-focused OngoingThis study tests a special PET scan (FES) that tracks estrogen receptors in breast cancer tumors. Researchers want to see if changes in scan results before, during, and after hormone therapy can show how well the treatment is working. The study involves adults with estrogen recep…
Phase: PHASE2 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
SISTER study: does a support buddy help beat cancer?
Knowledge-focused OngoingThis study looks at whether group support or one-on-one peer support helps Black patients with endometrial cancer complete their treatment. About 252 participants will be randomly assigned to one of three groups: group support, one-on-one peer support, or enhanced usual care. The…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC
-
Shorter wait for abortion confirmation?
Knowledge-focused OngoingThis study looks at whether a simple urine pregnancy test taken 2 weeks after a medication abortion can reliably show the abortion is complete, instead of waiting the usual 4 weeks. About 400 people with very early pregnancies (up to 42 days) will take weekly tests and answer sym…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:02 UTC
-
Writing away the urge: new study tests 20-Minute exercise to curb binge drinking
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether a 20-minute writing task can change how college seniors view themselves as drinkers and help them drink less after graduation. About 468 students from two universities will complete the writing exercise and answer surveys over a year. Researchers hope …
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:08 UTC
-
MRI scans aim to decode early breast cancer clues
Knowledge-focused OngoingThis study looks at whether special MRI scans can tell us more about early breast changes called DCIS, which show up as tiny calcium spots on mammograms. About 122 women with these spots or a recent DCIS diagnosis will get an MRI before surgery. The goal is to see if MRI can meas…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:27 UTC
-
HIV drug comparison study seeks clues to shrink hidden virus
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at 40 people with HIV to see if a common drug, tenofovir, causes more immune system activation and helps the virus hide better in the body. Participants are already on stable HIV treatment and will provide blood and gut samples. The goal is to find ways to reduce…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:10 UTC
-
Suicide prevention study pulled before starting
Knowledge-focused TerminatedThis study was designed to develop and test a new therapy model for young people aged 13-30 who have suicidal thoughts but don't need emergency care. The goal was to improve the bond between patient and therapist and reduce suicide risk. However, the study was withdrawn before en…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:05 UTC
-
New strategy aims to keep mental health patients on track in mozambique
Knowledge-focused OngoingThis study tests a new approach to help people with mental health conditions stay in treatment and get better. Researchers are working with 155 patients in Mozambique to see if a step-by-step improvement plan helps clinics diagnose, treat, and follow up more effectively. The goal…
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:05 UTC